DiscoverImmunity Group PodcastEpisode 39: Revolutionizing Allergy Treatment: Dr. Jose Costa on Early Exposure & Immunotherapy
Episode 39: Revolutionizing Allergy Treatment: Dr. Jose Costa on Early Exposure & Immunotherapy

Episode 39: Revolutionizing Allergy Treatment: Dr. Jose Costa on Early Exposure & Immunotherapy

Update: 2025-05-14
Share

Description

In this episode of the Immunity Group Australia Podcast, leading pediatric allergist Dr. Jose Costa shares how early allergen introduction, personalized care, and innovative immunotherapy protocols are transforming the way we treat allergies.


Dr. Costa opens up about his journey into allergy medicine and explains the science behind oral immunotherapy (OIT)—a treatment approach giving hope to families dealing with severe food allergies. He also discusses promising research using omalizumab (Xolair) to enhance OIT outcomes and why the UK is a critical next step in expanding access to care.


Learn how airborne allergen immunotherapy could help reduce food allergies, asthma, and eczema, and why outdated advice on allergen avoidance may be causing more harm than good. Dr. Costa's vision challenges the status quo and offers a new path forward for clinicians, parents, and allergy sufferers alike.

Comments 
loading
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Episode 39: Revolutionizing Allergy Treatment: Dr. Jose Costa on Early Exposure & Immunotherapy

Episode 39: Revolutionizing Allergy Treatment: Dr. Jose Costa on Early Exposure & Immunotherapy

Immunity Group Australia